These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Invited commentary. Hiramatsu Y Ann Thorac Surg; 2005 Jul; 80(1):257-8. PubMed ID: 15975377 [No Abstract] [Full Text] [Related]
10. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors]. Zettl H; Schubert-Zsilavecz M Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349 [No Abstract] [Full Text] [Related]
11. Design and synthesis of an orally active GPIIb/IIIa antagonist based on a phenylpiperazine scaffold. van Maarseveen JH; den Hartog JA; Tipker K; Reinders JH; Brakkee J; Schön U; Kehrbach W; Kruse CG Bioorg Med Chem Lett; 1998 Jun; 8(12):1531-6. PubMed ID: 9873384 [TBL] [Abstract][Full Text] [Related]
17. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011 [TBL] [Abstract][Full Text] [Related]
18. [The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides]. Marrakchi N; Guermazi S; El Ayeb M Arch Inst Pasteur Tunis; 1997; 74(1-2):9-15. PubMed ID: 15945171 [No Abstract] [Full Text] [Related]
19. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice. Iwatsuki Y; Kawasaki T; Hayashi K; Moritani Y; Nii T; Miyata K Thromb Haemost; 2004 Dec; 92(6):1221-8. PubMed ID: 15583727 [TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions. Ferguson JJ; Zaqqa M Drugs; 1999 Dec; 58(6):965-82. PubMed ID: 10651385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]